Displaying 61 - 67 of 67

Chemotherapy drug directed to tumour site through nanoparticles

The overall five-year survival rate for people with pancreatic cancer is just 6%, and there is an urgent need for new treatment options. More than 80% of pancreatic cancer diagnoses occur too late for surgery, making chemotherapy the only possible treatment. Scientists from the California NanoSystems Institute at UCLA and UCLA's Jonsson Comprehensive Cancer Center have developed a delivery system for one chemotherapy drug that greatly reduces the occurrence of serious side effects while enhancing the drug's effectiveness against pancreatic cancer.
4th March 2016

Engineered nanoparticles deliver cancer drugs to tumours

Engineered nanoparticles deliver cancer drugs to tumours
Chemotherapy isn't supposed to make your hair fall out—it's supposed to kill cancer cells. A new molecular delivery system created at U of T could help ensure that chemotherapy drugs get to their target while minimising collateral damage. Many cancer drugs target fast-growing cells. Injected into a patient, they swirl around in the bloodstream acting on fast-growing cells wherever they find them. That includes tumours, but unfortunately also hair follicles, the lining of your digestive system, and your skin.
19th February 2016

New hydrogel nanoplatform shrinks tumors in mice

Functionalised nanoparticles are one avenue of drug delivery for chemotherapeutics. However, getting nanoparticles to target the tumor site has proven difficult to do. One method researchers have used to target cancer cells is to create hydrogels made of filamentous bacteriophage (phage) and gold nanoparticles. Peptide binding ligands can be incorporated into the phage portion of the hydrogel that will then target known carcinoma cells.
17th February 2016

'Hybrid' nanocrystals aid targeted drug delivery

Researchers have taken a huge step closer to the engineering of nanoscale devices to aid the delivery of life-saving drug treatments. Research co-leader Professor Dayong Jin at UTS said such minute devices have the potential to be engineered to efficiently and more safely deliver drug treatments directly to the location of diseased cells while helping avoid harm to healthy cells that fall victim to toxic drugs administered by conventional means.
5th February 2016

Light-activated nanoparticles kill 'superbugs'

Light-activated nanoparticles kill 'superbugs'
In the ever-escalating evolutionary battle with drug-resistant bacteria, humans may soon have a leg up thanks to adaptive, light-activated nanotherapy developed by researchers at the University of Colorado Boulder. Antibiotic-resistant bacteria such as Salmonella, E. Coli and Staphylococcus infect some 2m people and kill at least 23,000 people in the United States each year.
21st January 2016

Research programme explores nanomedicine characterisation

CEA-Leti has announced the launch of the European Nano-Characterisation Laboratory (EU-NCL), funded by the European Union’s Horizon 2020 research and innovation programme. Its main objective is to reach a level of international excellence in nanomedicine characterisation for medical indications of cancer, diabetes, inflammatory diseases or infections, and make this accessible to all organisations developing candidate nanomedicines prior to their submission to regulatory agencies.
6th July 2015

NanoKTN Sparks New Nanomedicine Intelligence Start-Up: NanoScientium

The Nanotechnology Knowledge Transfer Network is pleased to announce the foundation of a new start-up company, NanoScientium, resulting from a NanoKTN NanoPharm focus group meeting held last year at the Stevenage Bioscience Catalyst (SBC).
12th February 2014

Nanomedicine documents

Sign up to view our publications

Sign up

Sign up to view our downloads

Sign up

The Digital Healthcare Show 2019
26th June 2019
United Kingdom EXCEL, London
HETT 2019
1st October 2019
United Kingdom EXCEL, London
GIANT Health Event 2019
15th October 2019
United Kingdom Chelsea Football Club Stadium, London